Ozempic maker Novo Nordisk failed to disclose more payments ... - Sky News
20 hours ago · The company behind popular weight-loss drugs failed to disclose even more money it paid to healthcare groups and patient organisations , a pharmaceutical watchdog has …
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug …
6 days ago · The agency announced last week that Ozempic and Wegovy, along with Novo's other semaglutide GLP-1 diabetes drug Rybelsus, are at the top of its list for 2027 Medicare …
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug …
Jan 21, 2025 · Will Medicare end Novo Nordisk's obesity drug boom? Behind Medicare's latest move It's not surprising that CMS chose Ozempic, Wegovy, and Rybelsus for Medicare drug …
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk …
Nov 6, 2024 · Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 …
Medicare announces 15 new drugs up for price negotiations ... - NBC News
Jan 17, 2025 · In a statement, a spokesperson for Novo Nordisk, the maker of Ozempic and Wegovy, said the drugmaker remains opposed to the pricing negotiations.
Ozempic maker’s stock surges. A trial of a new Novo Nordisk …
3 days ago · Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.
Novo Nordisk Stock Dives After Medicare Targets Ozempic, …
Jan 17, 2025 · Novo Nordisk (NVO) stock tumbled Friday after its weight-loss drug Wegovy and diabetes medicine Ozempic landed on Medicare's next list of drugs to face price negotiations.
Ozempic maker Novo Nordisk, after trial disappointment, …
Jan 8, 2025 · Ozempic weight-loss drug maker Novo Nordisk on Wednesday expanded an existing agreement with a drug developer that uses artificial intelligence.
Ozempic, Wegovy maker Novo Nordisk faces hearing over high …
Sep 24, 2024 · Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.
Ozempic maker defends high U.S. price: It's 'helping' reduce ... - NBC News
Aug 25, 2024 · The CEO of Novo Nordisk defended the high cost of Ozempic and Wegovy in the U.S., saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related …